Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
about
Automated solid-phase peptide synthesis to obtain therapeutic peptidesIntegrating solid-state NMR and computational modeling to investigate the structure and dynamics of membrane-associated ghrelinA Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo.Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extractGhrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice.Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food IntakeTaking two to tango: a role for ghrelin receptor heterodimerization in stress and reward.Peptide mini-scaffold facilitates JNK3 activation in cellsSilencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.Semagacestat, a γ-secretase inhibitor, activates the growth hormone secretagogue (GHS-R1a) receptor.Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical CandidateHigh constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs.Evaluation and synthesis of polar aryl- and heteroaryl spiroazetidine-piperidine acetamides as ghrelin inverse agonists.A Deep Hydrophobic Binding Cavity is the Main Interaction for Different Y2 R Antagonists.Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor.Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia.
P2860
Q27001623-1E590122-B310-405F-946B-B8DB93FA3B2EQ28544962-E0FE747C-2948-464F-8C85-66CF7A3035EAQ30827768-6AEC3AF5-04D4-4A9B-BB63-DCEF53CF87BAQ33961384-2FEC4FF5-2F37-4930-944E-13F87CB96D98Q35152716-7299C0F2-EF0E-4A40-B76F-BF81B2577184Q35885897-F65E1FE3-27F5-4817-AA83-B2B9DBB80895Q37132463-C41668CD-4A3F-4020-9ADC-35F7CEA1872AQ38380188-CDF6CA89-BF03-4C5D-AF7F-DE8D44BD51A7Q39143949-F0457F07-1153-441C-BFAE-1DA8DEF5101BQ39181374-B654BED1-03BD-4403-BFA4-D99EC884D19CQ39253697-68BBADC1-F0B0-4991-8BEE-6B15719C20B0Q39518263-10806B47-3C38-4268-A1FD-5B3ABE6C9523Q39786249-F2834BCE-41D3-41CE-A007-3472BEF6BD90Q41226865-D8C2018A-9F8F-40F3-ADFB-C3158DDFC5F2Q43148237-031EC594-27C6-4178-95A5-9EC2F2268CE1Q48206043-48800E5F-D006-4460-829E-611E4D94FAF1Q52316530-E61138D9-A114-40EB-BD0D-ADC0EED383FAQ55646811-6B9FDEB8-892E-4CBE-87B2-65D385A122D1
P2860
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@ast
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@en
type
label
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@ast
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@en
prefLabel
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@ast
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@en
P2093
P1476
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
@en
P2093
Annette G Beck-Sickinger
Constance Chollet
Sylvia Els
P304
P356
10.1016/B978-0-12-381296-4.00006-3
P407
P577
2010-01-01T00:00:00Z